Outpatient Chemotherapy with Oral UFT (Tegafur and Uracil) and Cisplatin against Metastatic Non-small Cell Lung Carcinoma. An Effective Case.
|
Accession number;99A0203865
|
| Title;Outpatient Chemotherapy with Oral UFT (Tegafur and Uracil) and Cisplatin against Metastatic Non-small Cell Lung Carcinoma. An Effective Case. |
| Author;
UEHARA TADASHI
(National Kyushu Cancer Center Hospital)
YANO TOKUJIRO
(Kyushu Univ., Fac. of Med.)
KANEMATSU TAKANORI
(National Kyushu Cancer Center Hospital)
TERAZAKI YASUHIRO
(National Kyushu Cancer Center Hospital)
KUNINAKA SHINJI
(National Kyushu Cancer Center Hospital)
FUKUYAMA YASURO
(National Kyushu Cancer Center Hospital)
YOKOYAMA HIDEKI
(National Kyushu Cancer Center Hospital)
ASO HIROSHI
(National Kyushu Cancer Center Hospital)
ICHINOSE YUKITO
(National Kyushu Cancer Center Hospital)
|
Journal Title;Japanese Journal of Cancer and Chemotherapy
|
Journal Code:Z0938A
|
ISSN:0385-0684
|
|
VOL.26;NO.1;PAGE.137-139(1999)
|
| Figure&Table&Reference;FIG.2, REF.5 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;A 64-year-old man underwent a left pneumonectomy for squamous cell carcinoma of the left lung in July 1995. In May 1996, right pelvic bone metastasis occurred and was well controlled by the concurrent chemoradiotherapy; UFT (600mg/body, day 1-14) and cisplatin (80mg/m2, day 8) with a total 50.4Gy of irradiation. In August 1996, left renal metastasis occurred, but regressed after two cycles of combination chemotherapy with UFT and cisplatin. In January 1997, multiple lung metastasis occurred. In accordance with the patient's request, combination chemotherapy was performed at the outpatient clinic. UFT (250mg/m2) was given orally every day while ciplatin (60-80mg/m2), fractionated in 3 or 5 days, was intravenously administered at an interval of 4 weeks or longer. The patient has continued the treatment for one year without serious (G3,4) adverse events. During the treatment, the tumor growth was slow with a repeated cycle of progression and regression. The outpatient chemotherapy using UFT and cisplatin is considered to be useful, especially for the better quality of life of patients. (author abst.) |
|
|
|
Related Articles;
|
|
|
